Patrick Cauntay is a senior research associate at Isis Pharmaceuticals, which is partnering with Bayer AG to develop a potential blockbuster drug.

Patrick Cauntay is a senior research associate at Isis Pharmaceuticals, which is partnering with Bayer AG to develop a potential blockbuster drug. Photo by Stephen Whalen.

Isis Pharmaceuticals has landed a megadeal with aspirin-maker Bayer AG to move a potential blockbuster drug from the lab to the market...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129